Evidence map›Paper›PMID 27349810›Full record

ArticleLeukemia2017

Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph

K Ishiyama, T Kitawaki, N Sugimoto, T Sozu, N Anzai, M Okada, M Nohgawa, K Hatanaka, N Arima, T Ishikawa and 9 more

Erratum issued Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03331211 (Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03331211 unknown statusnot on this map

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Typeobservational_patient_registrySponsorNanfang Hospital, Southern Medical UniversityRan2017 to 2019Enrolled100ConditionsLeukemia, Lymphoblastic, AcuteArmsTKIs
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 1 country.

K IshiyamaDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
T KitawakiDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
N SugimotoDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
T SozuDepartment of Management Science, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
N AnzaiDepartment of Hematology and Oncology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
M OkadaDepartment of Hematology and Oncology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
M NohgawaDepartment of Hematology, Wakayama Red Cross Hospital, Wakayama, Japan.
K HatanakaDepartment of Hematology, Wakayama Red Cross Hospital, Wakayama, Japan.
N ArimaDepartment of Hematology, Kitano Hospital, Osaka, Japan.
T IshikawaDepartment of Hematology, Kobe City Medical Center, Kobe, Japan.
S TabataDepartment of Hematology, Kobe City Medical Center, Kobe, Japan.
T OnakaDepartment of Hematology, Kokura Memorial Hospital, Kitakyusyu, Japan.
S OkaDepartment of Hematology and Oncology, Shiga Medical Center for Adults, Moriyama, Japan.
Y NakaboThe Center for Hematological Diseases, Takeda General Hospital, Kyoto, Japan.
R AmakawaDepartment of Hematology, The Japan Baptist Hospital, Kyoto, Japan.
M MatsuiDepartment of Hematology, Kyoto City Hospital, Kyoto, Japan.
T MoriguchiDepartment of Hematology, Kyoto-Katsura Hospital, Kyoto, Japan.
A Takaori-KondoDepartment of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7678-4284
N KadowakiDepartment of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Kyoto University · JPJapanese Red Cross Society Wakayama Medical Center · JPKobe City Nishi-Kobe Medical Center · JPTakatsuki Red Cross Hospital · JPIjinkai Takeda General Hospital · JPKagawa University · JPKitano Hospital · JPKokura Memorial Hospital · JPKyoto City Hospital · JPKyoto Katsura Hospital · JPShiga Medical Center for Adults · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dasatinib treatment markedly increases the number of large granular lymphocytes (LGLs) in a proportion of Ph

Indexed as

CytomegalovirusPrincipal Component AnalysisDasatinibHumansKiller Cells, NaturalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVirus ActivationDasatinib

Identifiers

PMID27349810
OpenAlexW2422028859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.